710
Views
10
CrossRef citations to date
0
Altmetric
Commentaries

Transdermal immunization of P. falciparum surface antigen (MSP-119) via elastic liposomes confers robust immunogenicity

, , &
Pages 990-992 | Received 15 Oct 2015, Accepted 01 Nov 2015, Published online: 07 Mar 2016

References

  • Tyagi RK, Garg NK, Jadon R, Sahu T, Katare OP, Dalai SK, Awasthi A, Marepally SK. Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119. Vaccine 2015; 33:4630-8; PMID:26141014; http://dx.doi.org/10.1016/j.vaccine.2015.06.054
  • Berzins K. Merozoite antigens involved in invasion. Chem Immunol 2002; 80:125-43; PMID:12058636; http://dx.doi.org/10.1159/000058843
  • Cowman AF, Baldi DL, Healer J, Mills KE, O'Donnell RA, Reed MB, Triglia T, Wickham ME, Crabb BS. Functional analysis of proteins involved in Plasmodium falciparum merozoite invasion of red blood cells. FEBS Lett 2000; 476:84-8; PMID:10878256; http://dx.doi.org/10.1016/S0014-5793(00)01703-8
  • Miller LH, Hoffman SL. Research toward vaccines against malaria. Nat Med 1998; 4:520-4; PMID:9585203; http://dx.doi.org/10.1038/nm0598supp-520
  • Holder AA, Freeman RR. Protective antigens of rodent and human bloodstage malaria. Philos Trans R Soc Lond B Biol Sci 1984; 307:171-7; PMID:6151681; http://dx.doi.org/10.1098/rstb.1984.0117
  • Blackman MJ, Holder AA. Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP133 as a noncovalently associated complex with other fragments of the MSP1. Mol Biochem Parasitol 1992; 50:307-15; PMID:1741018; http://dx.doi.org/10.1016/0166-6851(92)90228-C
  • Holder AA, Blackman MJ, Burghaus PA, Chappel JA, Ling IT, McCallum-Deighton N, Shai S. A malaria merozoite surface protein (MSP1)-structure, processing and function. Mem Inst Oswaldo Cruz 1992; 87:37-42; PMID:1343716; http://dx.doi.org/10.1590/S0074-02761992000700004
  • Ahlborg N, Ling IT, Holder AA, Riley EM. Linkage of exogenous T-cell epitopes to the 19-kgdalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19). Infect Immun 2000; 68:2102-9; PMID:10722607; http://dx.doi.org/10.1128/IAI.68.4.2102-2109.2000
  • Tian JH, Kumar S, Kaslow DC, Miller LH. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii. Infect Immun 1997; 65:3032-6; PMID:9234750
  • Glenn GM, Rao M, Matyas GR, Alving CR. Skin immunization made possible by cholera toxin. Nature 1998; 391:851; PMID:9495336; http://dx.doi.org/10.1038/36014
  • Foged C, Sundblad A, Hovgaard L. Targeting vaccines to dendritic cells. Pharm Res 2002; 19:229-38; PMID:11934227; http://dx.doi.org/10.1023/A:1014474414097
  • Glenn GM, Scharton-Kersten T, Alving CR. Advances in vaccine delivery: transcutaneous immunisation. Expert Opin Investig Drugs 1999; 8:797-805; PMID:15992132; http://dx.doi.org/10.1517/13543784.8.6.797
  • Shi Z, Curiel DT, Tang DC. DNA-based non-invasive vaccination onto the skin. Vaccine 1999; 17:2136-41; PMID:10367946; http://dx.doi.org/10.1016/S0264-410X(98)00488-5
  • Singh RP, Singh P, Mishra V, Prabhakaran D, Vyas SP. Vesicular systems for non-invasive topical immunization: rationale and prospects. Indian J Pharmacol 2002; 34:301-10.
  • Baca-Estrada ME, Foldvari M, Ewen C, Badea I, Babiuk LA. Effects of IL-12 on immune responses induced by transcutaneous immunization with antigens formulated in a novel lipid-based biphasic delivery system. Vaccine 2000; 18:1847-54; PMID:10699333; http://dx.doi.org/10.1016/S0264-410X(99)00379-5
  • Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52; PMID:9521319; http://dx.doi.org/10.1038/32588
  • Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V. Antigen-bearing langerhans cells in skin, dermal lymphatics and in lymph nodes. Cell Immunol 1976; 25:137-51; PMID:782728; http://dx.doi.org/10.1016/0008-8749(76)90105-2
  • Eagling EM. Immediate management of perforating injuries: lacerations with anterior and posterior segment damage. Trans Ophthalmol Soc U K 1982; 102:225-6; PMID:6963513
  • Hammond SA, Guebre-Xabier M, Yu J, Glenn GM. Transcutaneous immunization: an emerging route of immunization and potent immunostimulation strategy. Crit Rev Ther Drug Carrier Syst 2001; 18:503-26; PMID:11763499; http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v18.i5.30
  • Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992; 1104:226-32; PMID:1550849; http://dx.doi.org/10.1016/0005-2736(92)90154-E
  • Daly TM, Long CA. Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 1995; 155:236-43; PMID:7602100
  • Hirunpetcharat C, Tian JH, Kaslow DC, van Rooijen N, Kumar S, Berzofsky JA, Miller LH, Good MF. Complete protective immunity induced in mice by immunization with the 19-kgdalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells. J Immunol 1997; 159:3400-11; PMID:9317139
  • Tyagi RK, Garg NK, Sahu T. Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force. J Control Release 2012; 162:242-54; PMID:22564369; http://dx.doi.org/10.1016/j.jconrel.2012.04.037

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.